De La Soul To Lead ‘Good Health’ Summit at Morehouse College
The group is bringing together health experts, community leaders and others for the wellness event.
Kevin Mercer of De La Soul band performs on stage during the 79th edition of the Les Nuits de Fourviere at the Theatre Antique de Lyon Fourviere in Lyon, eastern France, on July 5,2025.
Photo by OLIVIER CHASSIGNOLE/AFP via Getty Images.
De La Soul is heading a summit on wellness at Morehouse College. The inaugural Good Health: Mind, Body & Soul Summit is happening on Feb. 19, and the invitation-only event is inspired by the music, legacy, and experiences of De La Soul. The summit is bringing together health, culture, science and community leaders to advance health equity for Black men and families.
They are teaming with LIXTE Biotechnology Holdings Inc, a clinical-stage pharmaceutical company that develops breakthrough cancer therapies. De La Soul’s song “Good Health” serves as a mantra for the event; written after the passing of founding member David Jolicoeur, also known as Trugoy the Dove.
“This Summit is about turning pain into purpose,” said Posdnuos. “We’ve always used our music to speak life — and Good Health is about making sure our people live long enough to tell their own stories.”
The Summit reflects the group’s evolution from musical pioneers to wellness advocates. “This isn’t just a conversation — it’s a call,” adds Maseo. “Good health is real wealth. We’re creating space for Black men, families and communities to own that truth — together.”
The Summit will convene an intimate audience of health experts, artists, entertainers, athletes, researchers, and advocates. Programming will span topics across mind, body and soul—including cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness—grounded in science and lived experience.
“Good Health aligns science with culture in a way that is both urgent and deeply human,” said Geordan Pursglove, CEO of LIXTE Biotechnology. “Through our first-in-class oncology compound, LB-100, and LIORA, our European research subsidiary, we are committed to advancing cancer care. This Summit is a powerful space to connect that innovation to the communities that need it most.”
